SCHEMBL29517801

SCHEMBL29517801

C1CCC(P(CCP(C2CCCCC2)C2CCCCC2)C2CCCCC2)CC1.Cl[Pd]Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18185630 0.90 CYP1A2 (0.30)
SCHEMBL18185592 0.90
SCHEMBL301349 0.89
SCHEMBL17585038 0.89
SCHEMBL8000320 0.86
SCHEMBL3891016 0.86
SCHEMBL17889761 0.84
Hydrochloric Acid SCHEMBL17421810 0.83
Bromide SCHEMBL2828926 0.83
Hydrochloric Acid SCHEMBL2831284 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111989311-B Compound for inhibiting PGE2/EP4 signal transduction, preparation method thereof and application thereof in medicines 凯复(苏州)生物医药有限公司 2022-03-22 CN disclosed